Ryan Cameron CEO, Electric Puppets Ryan Cameron has been a serial innovator since 1997. In 2000, Ryan led a team to create the first interactive versions of the beloved Little Golden Books for Disney Interactive, and then became CTO of an international US based firm that delivered online education to fortune 100 corporate employees. Ryan was CTO of online educational companies for the next 10 years before starting his own innovative online educational company, and advised on international boards and organizations as well. Ryan created online educational products that won numerous awards and helped hundreds of thousands of fortune 500 employees learn important new skills in multi-year award winning online programs. Ryan joined Copernicus Studios in 2013 and led the interactive division to create one of the first speech recognition engines tuned to children’s voices to empower early literacy applications, and then founded Electric Puppets in 2016. Ryan is an avid rare book and antique collector and lives on an acreage in Chester, Nova Scotia. Read the BioPort 2018 press release here ]]>
BIONOVA CONTACT
#46 1344 Summer Street
Halifax, Nova Scotia
Canada B3H 0A8
Phone: 902-421-5705
Fax: 902-421-2733
Email: [email protected]
Halifax, Nova Scotia
Canada B3H 0A8
Phone: 902-421-5705
Fax: 902-421-2733
Email: [email protected]

Recent Posts
- NEWS RELEASE: Doris Grant appointed Vice President Business Development and Strategy at BioNova
- MARS VR Lab
- Workinsights
- NEWS RELEASE: BioNova Announces MycoFutures North Atlantic as the Winner of the Eleventh Annual BioInnovation Challenge (BIC) at BioPort 2021
- NEWS RELEASE: BioNova’s BioPort 2021 Conference for Health and Life Sciences Kicks-Off Today
Business Wire National BioTech News
- Oragenics Project to Develop a Variant-Agnostic Protein Antigen for Use in its COVID-19 Intranasal Vaccine Receives Funding from CQDM
- BIOQuébec and MassBio Renew Their Memorandum of Cooperation and Collaboration
- MEDiC Life Sciences Announces Collaboration with Bristol Myers Squibb on Tumor Target Discovery
- At BIO 2023, Canada Showcases Multiple Strengths as a Biopharma Powerhouse
- Breast Cancer Canada Announces $3-million Precision Prevention Progress Funding to Princess Margaret Cancer Centre
- Enveric Biosciences Receives Notice of Allowance from USPTO for EVM301 Series of Drug Candidates
- Cybin Announces Scientific Management Transition Following Achievement of Final Adelia Milestones
- Anaergia Signs Contract to Build State-of-the-Art Food Waste and Wastewater Sludge Co-Digestion Facility at Monterey One Water in California
- KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Versus Chemotherapy Alone as First-Line Treatment for Unresectable Advanced Pleural Mesothelioma
- The Patient Safety Movement Foundation Concludes Its 10th Annual World Patient Safety, Science & Technology Summit
RECENT NEWS
- NEWS RELEASE: Doris Grant appointed Vice President Business Development and Strategy at BioNova February 9, 2023
- MARS VR Lab January 25, 2022
- Workinsights January 25, 2022
- NEWS RELEASE: BioNova Announces MycoFutures North Atlantic as the Winner of the Eleventh Annual BioInnovation Challenge (BIC) at BioPort 2021 November 8, 2021
- NEWS RELEASE: BioNova’s BioPort 2021 Conference for Health and Life Sciences Kicks-Off Today November 2, 2021
- NEWS RELEASE: BioNova Selects Eight Semi-Finalists to Participate in the 11th Annual BioInnovation Challenge August 24, 2021